Effect of antilymphocytic serum on the survival of renal homotransplants in dogs.

PubWeight™: 2.38‹?› | Rank: Top 2%

🔗 View Article (PMID 5339408)

Published in Transplantation on September 01, 1966

Authors

H M Abaza, B Nolan, J G Watt, M F Woodruff

Articles citing this

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Anti-lymphocytic antibody--a review. Clin Exp Immunol (1967) 2.75

Further experiments on the action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1967) 2.31

Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera. J Exp Med (1967) 1.57

Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53

Effect of antilymphocyte serum on animals experimentally infected with Histoplasma capsulatum or Cryptococcus neoformans. J Bacteriol (1969) 1.48

Macrophage specificity of antiserum against thymus lymphocytes. Clin Exp Immunol (1970) 1.12

The clinical use of antilymphocyte globulin in renal homotransplantation. Transplantation (1967) 1.09

Immunosuppression and its complications. Proc R Soc Med (1969) 0.89

Combined immunosuppression for canine renal allograft prolongation: antilymphocyte serum plus prednisolone or azathioprine. Ann Surg (1968) 0.86

Prolongation of canine renal allografts by horse anti-dog lymphocyte serum and globulin. Ann Surg (1969) 0.81

The present position and future prospects of organ transplantation. Ann R Coll Surg Engl (1968) 0.78

Prolonged administration of antithymocyte serum in mice. I. Observations on cellular and humoral immunity. Clin Exp Immunol (1971) 0.77

Antilymphocyte serum. Br Med J (1967) 0.75

Antilymphocyte serum: present status. Can Med Assoc J (1969) 0.75

Freezing and antilymphocytic globulin. Br Med J (1969) 0.75

Elimination of bacteria from dogs with antibiotics. J Hyg (Lond) (1974) 0.75

Antilymphocyte serum. Br Med J (1968) 0.75

Immunosuppression in relation to organ transplantation. Proc R Soc Med (1967) 0.75

Articles by these authors

A special-purpose processor for gene sequence analysis. Comput Appl Biosci (1993) 7.24

Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts. Br J Cancer (1966) 4.85

Paraquat poisoning--lung transplantation. Br Med J (1968) 4.29

Equity in the delivery of health care in Europe and the US. J Health Econ (2000) 3.84

Renal transplantation in man. Experience in 35 cases. Lancet (1969) 3.67

Equity in the finance of health care: some further international comparisons. J Health Econ (1999) 3.48

Equity in the finance of health care: some international comparisons. J Health Econ (1992) 3.43

A randomized comparison of helium-oxygen mixture (Heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics (2001) 2.86

Erythrocyte survival in normal mice and in mice with autoimmune haemolytic anaemia. Clin Exp Immunol (1966) 2.29

Clonal interaction in tumours. Nature (1982) 1.91

Effect of antilymphocytic antibody and antibody fragments on human lymphocytes in vitro. Nature (1967) 1.89

Ruptured abdominal aortic aneurysm. Br J Surg (1986) 1.74

Further observations on the effect of C. parvum and anti-tumour globulin on syngeneically transplanted mouse tumours. Br J Cancer (1972) 1.69

Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice. Clin Exp Immunol (1974) 1.69

Occupational class and ischemic heart disease mortality in the United States and 11 European countries. Am J Public Health (1999) 1.68

Acute ischaemia of the lower limb: the effect of centralizing vascular surgical services on morbidity and mortality. Br J Surg (1989) 1.66

Equity in the delivery of health care: some international comparisons. J Health Econ (1992) 1.60

Comparative effect of two strains of C. parvum on phagocytic activity and tumour growth. Nature (1968) 1.47

Microevolutionary changes in Candida albicans identified by the complex Ca3 fingerprinting probe involve insertions and deletions of the full-length repetitive sequence RPS at specific genomic sites. Microbiology (1999) 1.47

Anti-tumour effect in vitro of lymphocytes and macrophages from mice treated with Corynebacterium parvum. Br J Cancer (1974) 1.46

Possible implications of the effect of blood transfusion on allograft survival. Lancet (1983) 1.46

Ischaemia complicating injury. A report of thirty-seven cases. J Bone Joint Surg Br (1968) 1.44

Method for continuous drip therapy. Vet Rec (1966) 1.41

Effect of antilymphocytic antibody and antibody fragments on skin-homograft survival and the blood-lymphocyte count in rats. Lancet (1967) 1.41

Quality assurance in private veterinary laboratories. Vet Rec (1990) 1.39

Sleep events among veterans with combat-related posttraumatic stress disorder. Am J Psychiatry (1995) 1.35

Purification of antilymphocytic antibody. Nature (1968) 1.30

Synergistic inhibition of mammary carcinoma transplants in A-strain mice by antitumour globulin and C. parvum. Br J Cancer (1971) 1.29

Cellular heterogeneity in tumours. Br J Cancer (1983) 1.23

Health insurance and health services utilization in Ireland. Health Econ (2001) 1.23

Nocturnal/daytime urine noradrenergic measures and sleep in combat-related PTSD. Biol Psychiatry (1995) 1.22

Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice. J Natl Cancer Inst (1977) 1.21

Na+-Ca2+ exchanger remodeling in pressure overload cardiac hypertrophy. J Biol Chem (2001) 1.18

Unruptured aneurysm of the supraclinoid carotid artery. A treatable cause of blindness. Neurology (1970) 1.16

Prolongation of canine renal allograft survival with antilymphocytic serum. Transplantation (1968) 1.16

A comparative study of anaerobic Coryneforms. Attempts to correlate their anti-tumour activity with their serological properties and ability to stimulate the lymphoreticular system. Immunology (1975) 1.16

The effect of passage in vitro and in vivo on the properties of murine fibrosarcomas I. Tumorigenicity and immunogenicity. Br J Cancer (1985) 1.15

The redistributive effect of health care finance in twelve OECD countries. J Health Econ (1999) 1.14

Peripheral aneurysms in Behĉet's disease. Br J Surg (1976) 1.13

Quantitative studies with antilymphocytic antibody. Nature (1967) 1.13

Inhibition of the growth of lymphoid tumours in syngeneic athymic (nude) mice. Int J Cancer (1977) 1.11

Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma. Br J Cancer (1975) 1.09

A polysomnographic comparison of veterans with combat-related PTSD, depressed men, and non-ill controls. Sleep (1997) 1.08

Serum viscosity and hyperviscosity syndrome in IgG multiple myeloma. Report on 10 patients and a review of the literature. Ann Intern Med (1972) 1.06

Changing the paradigm: planning for ambulatory care expansion in Los Angeles County using a community-based and evidence-based model. J Ambul Care Manage (2000) 1.05

Sleep disturbance and its relationship to psychiatric morbidity after Hurricane Andrew. Am J Psychiatry (1995) 1.03

Inhibition of p38 mitogen activated protein kinase increases lipopolysaccharide induced inhibition of apoptosis in neutrophils by activating extracellular signal-regulated kinase. Surgery (2001) 1.02

The price of factor VIII. Lancet (1979) 1.01

The Nuffield transplantation surgery unit. Lancet (1968) 1.01

Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection. Sleep (1992) 1.00

Fatal cold anti-i autoimmune haemolytic anaemia complicating hairy cell leukaemia. Br J Haematol (2000) 0.97

Tibial defect due to acute haematogenous osteomyelitis: treatment and results in twenty-one children. J Bone Joint Surg Br (1979) 0.96

Effect of route of administration of antilymphocytic globulin on skin allograft survival in rats. Nature (1970) 0.95

Mechanisms of maurotoxin action on Shaker potassium channels. Biophys J (2000) 0.95

Elimination of normal horse IgG labelled with Iodine-131 in rats receiving horse anti-rat lymphocytic IgG. Nature (1967) 0.95

Fluid therapy for dehydration in calves. J Am Vet Med Assoc (1967) 0.95

Effect of C. parvum on the number and activity of macrophages in primary and transplanted murine fibrosarcomas. Br J Cancer (1982) 0.94

Intermittent haemodialysis: insertion and care of the silastic-teflon cannula. Br Med J (1967) 0.93

Comparative immunogenicity of antilymphocytic globulin in solution and adsorbed on lymphocytes. Nature (1968) 0.92

Antilymphocytic serum. Antibiot Chemother (1969) 0.92

Infusion of marrow and spleen cells in irradiated NZB-Bl mice: amelioration of autoimmune disease. Br J Haematol (1968) 0.92

Septic arthritis of the knee due to Clostridium bifermentans. Report of a case. J Bone Joint Surg Am (1972) 0.90

Results of kidney transplantation. Lancet (1970) 0.90

The intravenous administration of equine antilymphocytic globulin in renal transplant recipients and the detection of circulating antibodies to equine globulin. Clin Exp Immunol (1971) 0.90

Effect of acid treatment on the immunosuppressive properties of anti-lymphocytic IgG. Nature (1968) 0.89

Ten-year review of non-ruptured aortic aneurysms. Br J Surg (1989) 0.89

Long survival after renal transplantation in man. Br J Surg (1976) 0.86

Cytolytic efficiency of rabbit-anti-mouse antilymphocytic globulin and its augmentation by antiglobulin. Clin Exp Immunol (1971) 0.86

Effect of C. Parvum on immunization with irradiated tumour cells. Br J Cancer (1976) 0.86

Eligibility for free GP care, "need" and GP visiting in Ireland. Eur J Health Econ (2007) 0.86

The effect of Corynebacterium parvum therapy on immunoglobulin class and IgG subclass levels in cancer patients. Br J Cancer (1975) 0.85

Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum. Br J Cancer (1978) 0.85

Specificity of tumour associated transplantation antigens (TATA) of different clones from the same tumour. Br J Cancer (1984) 0.85

Low risk of inhibitor formation in haemophilia A patients following en masse switch in treatment to a third generation full length plasma and albumin-free recombinant factor VIII product (ADVATE®). Haemophilia (2011) 0.85

Tumor inhibitory properties of anaerobic Corynebacteria. Transplant Proc (1975) 0.85

Inhibition of alveolar neutrophil immigration in endotoxemia is macrophage inflammatory protein 2 independent. J Surg Res (2000) 0.84

The effect of prior administration of donor strain blood or blood constituents on the survival of cardiac allografts in rats. Transplantation (1971) 0.84

The recovery of immunoglobulin G from horses by combination of selective plasmapheresis and forced flow electrophoresis. Res Vet Sci (1970) 0.83

Modification of the effect of C. parvum on macrophage activity and tumour growth by X-irradiation. Int J Cancer (1976) 0.83

Antilymphocyte serum: summary and further observations. Transplantation (1967) 0.83

The effect of passage in vitro and in vivo on the properties of murine fibrosarcomas. II. Sensitivity to cell-mediated cytotoxicity in vitro. Br J Cancer (1985) 0.82

Multivessel coronary thrombosis resulting from heparin induced thrombocytopenia. Ir Med J (2007) 0.82

Zolpidem urine excretion profiles and cross-reactivity with ELISA(®) kits in subjects using Zolpidem or Ambien(®) CR as a prescription sleep aid. J Anal Toxicol (2011) 0.81

Acute ischaemia of the upper limb compared with acute lower limb ischaemia; a 5-year review. Br J Surg (1989) 0.79

The use of fluid replacement in the treatment of neonatal diseases in calves. Vet Rec (1965) 0.79

Burkholderia cepacia sepsis in neonates. Pediatr Infect Dis J (1995) 0.79

Control of large-scale plasma thawing for recovery of cryoprecipitate factor VIII. Vox Sang (1982) 0.79

Serological changes associated with C. parvum treatment in nude mice. Br J Cancer (1977) 0.78

Further studies on the serological effects of C. parvum immunotherapy in cancer patients. Dev Biol Stand (1978) 0.78

The effect of irradiation and infusion of marrow and spleen cells on autoimmune anemia in NZB/B1 mice. Proc R Soc Med (1967) 0.78

Mutation analysis of haemophilia B in the Irish population: increased prevalence caused by founder effect. Haemophilia (2008) 0.78

Neonatal pure red cell aplasia due to anti-M. Arch Dis Child Fetal Neonatal Ed (2006) 0.78

Studies on the lymphocytes of patients with renal homografts. Transplantation (1971) 0.77

Microalbuminuria in patients with non-insulin-dependent diabetes mellitus relates to nocturnal systolic blood pressure. Am J Med (1997) 0.77